MX2019001948A - Preparacion farmaceutica anti-envejecimiento. - Google Patents
Preparacion farmaceutica anti-envejecimiento.Info
- Publication number
- MX2019001948A MX2019001948A MX2019001948A MX2019001948A MX2019001948A MX 2019001948 A MX2019001948 A MX 2019001948A MX 2019001948 A MX2019001948 A MX 2019001948A MX 2019001948 A MX2019001948 A MX 2019001948A MX 2019001948 A MX2019001948 A MX 2019001948A
- Authority
- MX
- Mexico
- Prior art keywords
- liquid
- vessel
- containment means
- production method
- pharmaceutical preparation
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 3
- 230000003712 anti-aging effect Effects 0.000 title 1
- 239000007788 liquid Substances 0.000 abstract 9
- 230000001413 cellular effect Effects 0.000 abstract 4
- 239000000470 constituent Substances 0.000 abstract 4
- 238000004519 manufacturing process Methods 0.000 abstract 4
- 210000001808 exosome Anatomy 0.000 abstract 3
- 238000011534 incubation Methods 0.000 abstract 3
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
Abstract
La presente invención provee una preparación farmacéutica para ser utilizada mediante inyección en la piel, en la cual la preparación farmacéutica se puede preparar mediante un método de producción que comprende los pasos de proveer un líquido recolectado a partir de un organismo, cuyo líquido comprende constituyentes celulares de la sangre, proveer un recipiente o medios de contención, dicho recipiente o medios de contención tienen una superficie interna, y poner en contacto dicho líquido con dicho recipiente o medios de contención, en el cual (a) dicho método de producción también comprende el paso de incubar dicho líquido en dicho recipiente o medios de contención durante un tiempo de incubación, y opcionalmente retirar los constituyentes celulares de dicho líquido después de dicha incubación, (b) dicho líquido comprende exosomas, y dicho método de producción también comprende los pasos de concentrar dichos exosomas y opcionalmente retirar los constituyentes celulares de dicho líquido después de dicha concentración, o el paso de aislar dichos exosomas, o (c) dicho método de producción también comprende el paso de evitar la incubación de dicho líquido, y el paso de retirar los constituyentes celulares de dicho líquido que entra en contacto con dicho recipiente o medios de contención.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16001807 | 2016-08-17 | ||
| PCT/EP2016/001887 WO2017080668A1 (en) | 2015-11-13 | 2016-11-14 | Pharmaceutical preparation effective in age-related disorders |
| PCT/EP2016/001888 WO2017080669A1 (en) | 2015-11-13 | 2016-11-14 | Pharmaceutical preparation effective in age-related disorders |
| PCT/EP2017/000574 WO2018033226A1 (en) | 2016-08-17 | 2017-05-11 | Anti-ageing pharmaceutical preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019001948A true MX2019001948A (es) | 2019-05-15 |
Family
ID=61196401
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019001948A MX2019001948A (es) | 2016-08-17 | 2017-05-11 | Preparacion farmaceutica anti-envejecimiento. |
| MX2019001949A MX2019001949A (es) | 2016-08-17 | 2017-05-12 | Preparacion farmaceutica anti-envejecimiento. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019001949A MX2019001949A (es) | 2016-08-17 | 2017-05-12 | Preparacion farmaceutica anti-envejecimiento. |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20190290689A1 (es) |
| EP (4) | EP3352769A1 (es) |
| JP (2) | JP2019528281A (es) |
| KR (2) | KR20190049690A (es) |
| CN (2) | CN108348548A (es) |
| AU (2) | AU2017313163B2 (es) |
| BR (1) | BR112019002982A2 (es) |
| CA (2) | CA3033045A1 (es) |
| CL (2) | CL2019000419A1 (es) |
| CO (2) | CO2019001232A2 (es) |
| CR (2) | CR20190139A (es) |
| EA (2) | EA201890841A1 (es) |
| HK (3) | HK1258712A1 (es) |
| IL (2) | IL259007B2 (es) |
| MA (2) | MA42963A (es) |
| MX (2) | MX2019001948A (es) |
| PE (2) | PE20190627A1 (es) |
| PH (2) | PH12019550017A1 (es) |
| SG (2) | SG11201900866YA (es) |
| TW (2) | TW201806605A (es) |
| WO (3) | WO2018033226A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190049690A (ko) * | 2016-08-17 | 2019-05-09 | 오르토겐 아게 | 항-노화 약학 제제 |
| CN108841784A (zh) * | 2018-07-17 | 2018-11-20 | 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 | 一种含黄芪甲苷的髓核细胞抗衰老抗凋亡培养基 |
| EP3613424A1 (en) | 2018-08-23 | 2020-02-26 | Orthogen AG | Novel methods for the production of pharmaceutical agents |
| AU2019417521A1 (en) * | 2018-12-27 | 2021-06-17 | Suntory Holdings Limited | Agent for inhibiting reduction in decomposition of denatured elastin, agent for maintaining normal elastin fibers, agent for inhibiting formation of elastin-elafine composite, and screening method for substance having elastin-elafine composite formation inhibitory effect |
| RU2695264C1 (ru) * | 2018-12-27 | 2019-07-22 | федеральное государственное бюджетное образовательное учреждение высшего образования "Хакасский государственный университет им. Н.Ф. Катанова" (ФГБОУ ВО ХГУ им. Н.Ф. Катанова) | Способ прогнозирования ускоренного старения организма женщин, основанный на клинических данных о состоянии репродуктивной функции |
| EP3845566A1 (en) | 2019-12-30 | 2021-07-07 | Industrial Technology Research Institute | Extracellular vesicle separation method, colloidal particle and preparation method thereof |
| US12077780B2 (en) | 2020-02-14 | 2024-09-03 | Allergan Sales, Llc | Conditioned medium from cells cultured under hypoxic conditions and uses thereof |
| US20250186498A1 (en) * | 2022-05-16 | 2025-06-12 | Taiwan Mitochondrion Applied Technology Co., Ltd. | Composition for hearing loss mitigation and use thereof |
| JP7624256B1 (ja) | 2024-01-26 | 2025-01-30 | 万里 坂井 | 医薬組成物及びその製造方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008505104A (ja) * | 2004-07-01 | 2008-02-21 | ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション | 免疫抑制性エキソソーム |
| DE102006005016A1 (de) * | 2006-02-03 | 2007-08-16 | Orthogen Ag | Konditionierte Blutzusammensetzung und Verfahren zu deren Herstellung |
| DE202009017772U1 (de) * | 2009-12-10 | 2011-04-21 | Orthogen Ag | Kombinationspräparate mit Cytokin-Antagonist und Corticosteroid |
| WO2012076193A1 (de) * | 2010-12-10 | 2012-06-14 | Orthogen Ag | Kombinationspräparate mit exosomen und corticosteroid |
| JP6433896B2 (ja) * | 2012-08-13 | 2018-12-05 | シーダーズ−サイナイ・メディカル・センターＣｅｄａｒｓ−Ｓｉｎａｉ Ｍｅｄｉｃａｌ Ｃｅｎｔｅｒ | 組織再生のためのエキソソームおよびマイクロリボ核酸 |
| DE102012019088A1 (de) * | 2012-09-28 | 2014-04-03 | Orthogen Ag | Antibakterielle Arzneimittelpräparate |
| CN103767985A (zh) * | 2012-10-22 | 2014-05-07 | 吉林省霍普金斯药物研究院有限责任公司 | 人源血液或间充质干细胞分泌exosome的制备与应用 |
| KR101784050B1 (ko) * | 2014-12-23 | 2017-10-10 | 영남대학교 산학협력단 | 엑소솜을 유효성분으로 함유하는 피부 노화 예방 또는 치료용 약학조성물 |
| WO2017080668A1 (en) * | 2015-11-13 | 2017-05-18 | Orthogen Ag | Pharmaceutical preparation effective in age-related disorders |
| CN105477016A (zh) * | 2015-11-13 | 2016-04-13 | 中国人民解放军第二军医大学 | 人间充质干细胞来源的外泌体在抗组织纤维化及瘢痕形成中的应用 |
| CN105505854B (zh) * | 2016-01-14 | 2019-07-12 | 上海市第六人民医院 | 来源于人尿液细胞的外泌体的获取方法与应用 |
| CN105582576B (zh) * | 2016-02-23 | 2018-08-17 | 武汉大复生物科技有限公司 | 提高内皮祖细胞外泌体释放并促进骨缺损修复的生物材料、制备方法及用途 |
| KR20190049690A (ko) * | 2016-08-17 | 2019-05-09 | 오르토겐 아게 | 항-노화 약학 제제 |
-
2017
- 2017-05-11 KR KR1020197003441A patent/KR20190049690A/ko not_active Ceased
- 2017-05-11 HK HK19101113.9A patent/HK1258712A1/zh unknown
- 2017-05-11 IL IL259007A patent/IL259007B2/en unknown
- 2017-05-11 EA EA201890841A patent/EA201890841A1/ru unknown
- 2017-05-11 EP EP17728051.8A patent/EP3352769A1/en not_active Withdrawn
- 2017-05-11 MX MX2019001948A patent/MX2019001948A/es unknown
- 2017-05-11 AU AU2017313163A patent/AU2017313163B2/en active Active
- 2017-05-11 MA MA042963A patent/MA42963A/fr unknown
- 2017-05-11 CA CA3033045A patent/CA3033045A1/en active Pending
- 2017-05-11 WO PCT/EP2017/000574 patent/WO2018033226A1/en not_active Ceased
- 2017-05-11 CN CN201780003804.9A patent/CN108348548A/zh active Pending
- 2017-05-11 JP JP2019508969A patent/JP2019528281A/ja active Pending
- 2017-05-11 US US16/325,870 patent/US20190290689A1/en not_active Abandoned
- 2017-05-11 PE PE2019000304A patent/PE20190627A1/es not_active Application Discontinuation
- 2017-05-11 CR CR20190139A patent/CR20190139A/es unknown
- 2017-05-11 EP EP20155846.7A patent/EP3695845A1/en active Pending
- 2017-05-11 SG SG11201900866YA patent/SG11201900866YA/en unknown
- 2017-05-12 EA EA201890840A patent/EA201890840A1/ru unknown
- 2017-05-12 MA MA042964A patent/MA42964A/fr unknown
- 2017-05-12 HK HK18114754.7A patent/HK1255619A1/zh unknown
- 2017-05-12 MX MX2019001949A patent/MX2019001949A/es unknown
- 2017-05-12 TW TW106115815A patent/TW201806605A/zh unknown
- 2017-05-12 PE PE2019000361A patent/PE20190517A1/es not_active Application Discontinuation
- 2017-05-12 CR CR20190091A patent/CR20190091A/es unknown
- 2017-05-12 WO PCT/EP2017/000581 patent/WO2018033227A1/en not_active Ceased
- 2017-05-12 CA CA3033899A patent/CA3033899A1/en not_active Abandoned
- 2017-05-12 BR BR112019002982-6A patent/BR112019002982A2/pt not_active Application Discontinuation
- 2017-05-12 SG SG11201901085RA patent/SG11201901085RA/en unknown
- 2017-05-12 AU AU2017313164A patent/AU2017313164B2/en active Active
- 2017-05-12 EP EP17728052.6A patent/EP3352770A1/en not_active Withdrawn
- 2017-05-12 CN CN201780003805.3A patent/CN108348549A/zh active Pending
- 2017-05-12 KR KR1020197004442A patent/KR20190046793A/ko not_active Withdrawn
- 2017-05-12 HK HK19101111.1A patent/HK1259143A1/zh unknown
- 2017-05-12 TW TW106115816A patent/TW201806606A/zh unknown
- 2017-05-12 EP EP20163717.0A patent/EP3763377A1/en not_active Withdrawn
- 2017-05-12 JP JP2019508931A patent/JP2019529357A/ja active Pending
- 2017-05-12 US US16/325,945 patent/US20210290671A1/en not_active Abandoned
- 2017-08-17 WO PCT/EP2017/000994 patent/WO2018033249A1/en not_active Ceased
- 2017-08-17 US US16/325,944 patent/US20190231816A1/en not_active Abandoned
-
2018
- 2018-04-29 IL IL259006A patent/IL259006A/en unknown
-
2019
- 2019-01-30 PH PH12019550017A patent/PH12019550017A1/en unknown
- 2019-02-08 PH PH12019550022A patent/PH12019550022A1/en unknown
- 2019-02-12 CO CONC2019/0001232A patent/CO2019001232A2/es unknown
- 2019-02-13 CO CONC2019/0001265A patent/CO2019001265A2/es unknown
- 2019-02-15 CL CL2019000419A patent/CL2019000419A1/es unknown
- 2019-02-15 CL CL2019000420A patent/CL2019000420A1/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019550017A1 (en) | Anti-Ageing Pharmaceutical Preparation | |
| EP4300070A3 (en) | Culture patch, culture method, method and apparatus for testing culture, and method and apparatus for testing medicine | |
| EP4556576A3 (en) | Methods to diagnose and treat acute respiratory infections | |
| WO2013036863A3 (en) | Efficient use of ionic liquids | |
| WO2016145366A8 (en) | Systems and methods for serial staining and imaging | |
| MX2019015324A (es) | Instrumento de extraccion comprimible para pretratar una muestra. | |
| SG11201811521SA (en) | Method for preparing specimen for analysis or observation of skin | |
| MX375546B (es) | Método y aparato in vitro para analizar el comportamiento de sustancias en ambiente fisiológico simulado. | |
| MY199249A (en) | Immunochromatographic test piece and specimen adding device for extracting and measuring sugar chain antigen, and immunochromatography method using same | |
| EP3161165A4 (en) | Method for diagnosing subclinical and clinical acute rejection by analysis of predictive gene sets | |
| WO2016004250A3 (en) | Biological characterization of a glatiramer acetate related drug product using mammalian and human cells | |
| SG11202104757YA (en) | Membrane for separation of stem cells from biological samples, production process of said membrane, and process and device for separation, comprising said membrane | |
| MX2015007494A (es) | Metodo para diagnosticar leucodistrofia metacromatica. | |
| WO2014176167A3 (en) | Drug concentration from an oral fluid | |
| NZ745735A (en) | Method for detecting or separating/obtaining circulating tumor cell employing cell proliferation method | |
| UA96714U (ru) | Способ определения токсичности рыбы | |
| FI20145446A7 (fi) | Menetelmä prosessilaitteen valmistamiseksi ja prosessilaite | |
| MX2016015799A (es) | Aparato, sistemas y metodos para detectar un analito tal como etanol. | |
| MX357018B (es) | Método de diagnóstico temprano de carcinoma hepatocelular. | |
| Cheng et al. | Applying DNA Barcoding Technique to Identify Traditional SHE Medicine Shi-Liang-Cha and Some Chimonanthus Species | |
| GB2576331B8 (en) | Fixative solution and method of preparation of biological sample for examination | |
| UA95577U (uk) | Спосіб діагностики активності стеатогепатиту у хворих на неалкогольну жирову хворобу печінки | |
| IN2014MU00687A (es) | ||
| UA62320U (ru) | Способ диагностики состояния микроциркуляции крови в норме и патологии | |
| UA70773U (ru) | Способ диагностики острого криза отторжения почечного аллотрансплантата |